PARSABIV

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Singapore, Spain, Turkey, UK.

Active ingredients

The drug PARSABIV contains one active pharmaceutical ingredient (API):

1	Etelcalcetide UNII 72PT5993DU - ETELCALCETIDE HYDROCHLORIDE
	Etelcalcetide is a synthetic peptide calcimimetic agent which reduces PTH secretion through binding and activation of the calcium-sensing receptor. Etelcalcetide is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on haemodialysis therapy.
	Read more about Etelcalcetide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PARSABIV Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H05BX04		H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05B Anti-parathyroid agents → H05BX Other anti-parathyroid agents
Discover more medicines within H05BX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1733217, 1733228, 1733239, 1733240, 1733251, 1733262, 1733273, 1733284, 1733295, 1733307, 1733318, 1733329
ES	Centro de información online de medicamentos de la AEMPS	1161142002, 1161142006, 1161142010
FI	Lääkealan turvallisuus- ja kehittämiskeskus	035992, 448419, 588212
FR	Base de données publique des médicaments	61970183, 67061971, 69279221
GB	Medicines & Healthcare Products Regulatory Agency	343642, 344870, 344874
HK	Department of Health Drug Office	65657, 65658, 65659
IL	מִשְׂרַד הַבְּרִיאוּת	8104, 8121, 8122
IT	Agenzia del Farmaco	045182019, 045182021, 045182033, 045182045, 045182058, 045182060, 045182072, 045182084, 045182096, 045182108, 045182110, 045182122
JP	医薬品医療機器総合機構	3999443A1025, 3999443A2021, 3999443A3028, 3999443G1028, 3999443G2024, 3999443G3020
LT	Valstybinė vaistų kontrolės tarnyba	1081609, 1081610, 1081611, 1081612, 1081613, 1081614, 1081615, 1081616, 1081617, 1081618, 1081619, 1081620
NL	Z-Index G-Standaard, PRK	137480, 137499, 137502
PL	Rejestru Produktów Leczniczych	100381915, 100381921, 100381938
SG	Health Sciences Authority	15450P, 15451P, 15452P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699862770033, 8699862770040, 8699862770057, 8699862770064, 8699862770071, 8699862770088, 8699862770095, 8699862770101, 8699862770118
US	FDA, National Drug Code	55513-740, 55513-741, 55513-742